Pre-Market 20 Mar 2026: 1B1.SI HC Surgical S$0.365 on heavy volume, watch targets

1B1.SI stock is trading pre-market at S$0.365 on 20 Mar 2026 with 115,300 shares, a 6.23x surge vs average volume. The price is up 4.29% from yesterday’s close of S$0.350, and intraday range sits at S$0.360–S$0.365. For high-volume movers, volume spikes often precede short-term volatility. We summarise the drivers, valuation, technicals, and a concise Meyka AI view so traders on the SES can act with context

Pre-market volume and price action for 1B1.SI stock

1B1.SI shows outsized pre-market activity with 115,300 shares traded versus 18,513 average volume. The rel. volume is 6.23x, signalling institutional or event-driven flows. Price sits at S$0.365, close to the 50-day average S$0.364 and above the 200-day S$0.34338, suggesting near-term support.

Company fundamentals and valuation

HC Surgical Specialists Limited (1B1.SI) is listed on the SES in Singapore and has market cap S$55.98M with 153,375,507 shares outstanding. Key metrics: EPS S$0.06, PE 6.08, price-to-book 2.68, and dividend yield 5.70%. Profitability ratios are strong: net margin 47.09%, ROE 34.20%, and current ratio 1.72, which supports a defensive small-cap healthcare profile.

Technical setup and short-term trade signals

RSI is 59.58 and CCI at 187.68, indicating bullish momentum and short-term overbought readings. Bollinger band middle is S$0.36 with an upper band at S$0.38, so the stock is trading near the band midpoint. Watch intraday support S$0.360 and resistance S$0.385 (year high). Traders may favour tight stops given the elevated volume.

Meyka AI grade, forecast and model view

Meyka AI rates 1B1.SI with a score out of 100: 70.49 / 100 | Grade B+ | Suggestion: BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a monthly price of S$0.35, compared with the current S$0.365, implying a -4.11% move. Forecasts are model-based projections and not guarantees. See the Meyka stock page for live tools: Meyka stock page.

Sector context, catalysts and news

Healthcare names on the SES have mixed 3M performance and an average PE around 21.53; HC Surgical trades at a discount on PE. Recent comparative coverage lists HC Surgical among local clinic peers. Relevant industry news appears on Investing.com.source 1 and source 2. Key risks: patient volume sensitivity and margin pressure from rising costs.

Trading takeaways and price targets

For short-term traders, the volume spike supports momentum trades above S$0.360 with stop-loss near S$0.352. Our practical price targets: near-term S$0.42 (upside 15.07%) and conservative downside target S$0.32 (downside -12.33%). These targets align with the stock’s year range S$0.27–S$0.385 and current liquidity conditions. Maintain position sizing discipline on high-volume moves.

Final Thoughts

HC Surgical Specialists (1B1.SI) is a high-volume mover in the pre-market session on 20 Mar 2026, trading at S$0.365 with 115,300 shares and a 6.23x volume spike. Fundamentals support interest: EPS S$0.06, PE 6.08, ROE 34.20%, and dividend yield 5.70%. Meyka AI rates the stock 70.49/100 (B+, BUY) and projects a monthly model price of S$0.35, implying -4.11% from the current price; forecasts are model-based and not guarantees. For traders on the SES, the high relative volume plus technical momentum suggests opportunity for short-term momentum plays, while investors should weigh clinic-level patient flow risk and sector comparisons before adding exposure. Use tight risk controls if trading the volume-driven move

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.